Technology Transfer Readiness Workbook

The product, strengths, dosage forms, packs, sending and receiving units, markets, intended scale, purpose, target dates and explicit exclusions are approved.

Named sending- and receiving-unit leads and accountable functions cover Quality, production, packaging, engineering, QC, validation, regulatory, supply, procurement, data/IT and EHS.

Responsibilities for knowledge, samples, deviations, changes, data, records, complaints, recalls, audits and regulatory communication are clear where entities differ.

Each market is mapped for site addition, manufacturing and analytical changes, comparability, validation, stability, artwork and implementation timing.

The transfer and all resulting adaptations are linked to controlled changes with implementation conditions and effectiveness review.

Meeting frequency, decision authority, issue escalation, schedule control and reporting expectations are operating across both units.

Quality, patient, compliance, supply, data, safety, schedule and business risks have owners, controls, due dates and residual-risk decisions.

Every gate records evidence reviewed, open actions, accepted residual risk, conditions, approvers and the authorization to proceed or hold.

The receiving unit has the approved formula, process, specifications, methods, sites, suppliers, packaging, stability commitments and applicable variations for each market.

Intended use, dosage form, strength, release profile, stability, microbiological and packaging requirements are linked to justified CQAs.

Formulation rationale, experiments, scale history, failed approaches, edge-of-failure knowledge and design assumptions are available and discussed.

Unit operations, material attributes, CPPs/KPPs, proven ranges, IPCs, sampling, alarms, yields, hold times and response rules are connected to quality attributes.

Deviations, OOS/OOT, complaints, recalls, APR/PQR trends, stability trends, CAPA, process capability and inspection observations inform the transfer risk assessment.

Container-closure rationale, component attributes, line settings, transport risks, photostability/moisture risks, shelf life and ongoing commitments are understood.

Critical skills and judgement not fully captured in documents are identified for observation, demonstration, supervised practice or secondment.

Questions, missing items, contradictions, assumptions and unusable data are logged and resolved before site-fit decisions are finalized.

Every API, excipient, processing aid, primary/secondary component and printed item matches the formula, dossier, specifications and commercial presentation.

Manufacturers, brokers, repackers, test sites, warehouses and transport providers are identified with approval and traceability status.

Sufficient commercial-representative material lots are available for characterization, methods, engineering, validation, cleaning and stability without uncontrolled substitution.

Forecast, foreign exchange, purchase, shipment, customs, sampling, testing and usable-release dates support the transfer and launch sequence.

Sampling plans, identity testing, reduced-testing justification, COA verification, retention samples and material status controls are approved.

Dimensions, compatibility, barrier performance, machinability, supplier controls, artwork, coding and market text are approved and line-trial quantities are available.

Agreements define advance notice and assessment for site, process, source, grade, specification, method and subcontractor changes.

Differences in source, grade, particle properties, moisture, impurity profile or functional attributes are scientifically assessed and studied where required.

Personnel, material, waste and product flows; zoning; segregation; sampling; dispensing; storage and support spaces suit the product and process.

HVAC, water, gases, compressed air, temperature, humidity, power and backup/recovery controls meet process and product needs.

Geometry, working volume, energy input, control modes, ranges, product-contact materials, sampling and scale dependencies are compared—not just equipment names or capacities.

URS, design review, installation, operation and performance evidence cover product-specific functions, ranges, alarms, interfaces and data capture.

Access, master data, recipes, calculations, interfaces, audit trails, backup, time synchronization, review and retention are validated or otherwise controlled for intended use.

Preventive work, calibration ranges, service support, spare parts, drawings, passwords and failure-response arrangements support reliable operation.

Equipment design, product-contact surfaces, disassembly, drainage, dust control, hazardous-product segregation and cleaning access support the contamination-control strategy.

Critical punch items, commissioning changes, qualification deviations and as-built/configuration records are resolved before product exposure.

Master formulae, instructions, IPCs, sampling, reconciliation, hold-time and deviation requirements reflect approved knowledge and receiving-site capability.

Set-points, ranges, endpoints, alarms and allowed adjustments are linked to process purpose, equipment behavior and affected quality attributes.

Line clearance, component issue, coding, vision/inspection, challenge tests, reconciliation, rework and reject handling suit every intended presentation.

Operators, supervisors, samplers and reviewers can perform critical steps and respond to expected abnormalities under observation.

The batch purpose, materials, scale, parameters, sampling, observations, acceptance logic and restrictions on use are defined before execution.

Actual mixing, granulation, drying, compression, filling, coating or packing behavior is compared with transferred knowledge and justified ranges.

Expected yields, losses, material balance, bulk and packed reconciliation and intermediate/bulk hold times are feasible at the receiving site.

Production and packaging owners accept the control strategy, monitoring, open commitments, escalation rules and knowledge repositories after transfer.

Release, IPC, raw-material, packaging, cleaning, microbiological and stability methods match the dossier, pharmacopoeia and intended receiving-site use.

Comparative testing, co-validation, verification, revalidation or waiver is justified by method status, complexity, laboratory experience and risk, with predefined criteria.

Qualified reference standards, impurity standards, columns, filters, reagents, cultures and consumables are available with traceability and suitable storage.

Instrument range, qualification, calibration, software configuration, calculations, access, audit trails and environmental needs support method performance.

Analysts understand method intent, critical steps, sample preparation, known sensitivities, troubleshooting boundaries and data-recording expectations.

Representative, homogeneous and stable samples; randomized or predefined sequences; replicates; shipping and chain of custody support unbiased comparison.

All atypical results, invalidations, protocol departures and statistical comparisons are investigated before a conclusion; acceptance criteria are not changed after results.

Controlled methods, specifications, worksheets/LIMS, calculations, review, OOS, audit-trail review, turnaround capacity and sample retention are operational.

Facility, utility, equipment, computerized-system, method, cleaning, hold-time, transport and process-validation activities are sequenced with responsibilities and dependencies.

Worst cases, HBEL/PDE basis where relevant, limits, recovery, sampling locations, methods, campaign rules and dirty/clean hold times address transferred products and equipment.

Critical qualification, methods, materials, suppliers, documents, training, cleaning, deviations, change and regulatory prerequisites are closed or formally accepted.

Batch count, scale, lots, operating conditions, sampling, tests, statistics, acceptance criteria, deviations and disposition are scientifically justified before execution.

Commercial-representative execution, enhanced sampling and complete data demonstrate within- and between-batch consistency and explain unexpected variation.

Representative batches, packs, conditions, tests, time points, storage, pull schedules, OOS/OOT handling and market commitments are controlled.

Parameters, attributes, yields, deviations, laboratory, stability and material signals have owners, frequencies, statistical or trend rules and escalation thresholds.

Qualification, analytical, cleaning, process and stability evidence are integrated; departures, remaining commitments and revalidation triggers are transparent.

Required approvals, notifications, licence scope and dossier updates are effective for the receiving site, process, testing, suppliers, packs and markets.

Approved artwork, product codes, BOMs, recipes, shelf life, storage, serialization/coding where applicable and ERP/LIMS master data are reconciled.

Status control, storage, FEFO, transport, temperature monitoring, customer traceability, returns and recall interfaces support the intended markets.

Authorized Quality can review the complete manufacturing, packaging, laboratory, deviation, change, validation and regulatory history before disposition.

Demand, materials, capacity, QC turnaround, release timing, shelf life, working capital and contingency assumptions are aligned with validated capability.

Initial routine batches are monitored against predefined process, product, laboratory, yield, deviation, complaint and supply criteria with escalation rules.

Stability, validation, regulatory, CAPA, supplier, training and monitoring commitments have owners, due dates, escalation and management visibility.

The report reconciles scope, protocol, results, deviations, changes, investigations, approvals, residual risks, commitments, lessons and handover; closure is not based only on PPQ completion.